Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease
Journal of the American Heart Association · 2024
DOI: 10.1161/jaha.123.033278 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Lori C Jordan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurology, Department of Pediatrics Vanderbilt University Medical Center Nashville TN. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Magnetic Resonance Imaging, Recurrence, Cerebral Infarction. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NICHD NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Background
Most adults with sickle cell disease will experience a silent cerebral infarction (SCI) or overt stroke. Identifying patient subgroups with increased stroke incidence is important for future clinical trials focused on stroke prevention. Our 3‐center prospective cohort study tested the primary hypothesis that adults with sickle cell disease and SCIs have a greater incidence of new stroke or SCI compared with those without SCI. A secondary aim focused on identifying additional risk factors for progressive infarcts, particularly traditional risk factors for stroke in adults. Methods and Results This observational study included adults with sickle cell disease and no history of stroke. Magnetic resonance imaging scans of the brain completed at baseline and >1 year later were reviewed by 3 radiologists for baseline SCIs and new or progressive infarcts on follow‐up magnetic resonance imaging. Stroke risk factors were abstracted from the medical chart. Time‐to‐event analysis was utilized for progressive infarcts. Median age was 24.1 years; 45.3% of 95 participants had SCIs on baseline magnetic resonance imaging. Progressive infarcts were present in 17 participants (17.9%), and the median follow‐up was 2.1 years. Incidence of new infarcts was 11.95 per 100 patient‐years (6.17–20.88) versus 3.74 per 100 patient‐years (1.21–8.73) in those with versus without prior SCI. Multivariable Cox regression showed that baseline SCI predicts progressive infarcts (hazard ratio, 3.46 [95% CI, 1.05–11.39]; P =0.041); baseline hypertension was also associated with progressive infarcts (hazard ratio, 3.23 [95% CI, 1.16–9.51]; P =0.025).
Conclusions
Selecting individuals with SCIs and hypertension for stroke prevention trials in sickle cell disease may enrich the study population with those at highest risk for infarct recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Neurology, Department of Pediatrics Vanderbilt University Medical Center Nashville TN.
- Division of Hematology & Oncology, Department of Pediatrics Washington University School of Medicine St. Louis MO.
- Division of Hematology-Oncology, Department of Medicine University of Alabama at Birmingham Heersink School of Medicine Birmingham AL.
- Division of Hematology-Oncology, Department of Pediatrics University of Alabama at Birmingham, Heersink School of Medicine Birmingham AL.
- Department of Neurology Washington University School of Medicine St. Louis MO.
- Division of Hematology, Department of Medicine Washington University School of Medicine St. Louis MO.
ORCID-Profile: Lori C Jordan, Allison A King, Julie Kanter, Andria L Ford, Taniya E Varughese, LeShana Saint Jean, Samantha Davis, Adetola A Kassim, Mark Rodeghier, Mohammad A Suwaid, Michael R DeBaun
Förderung
- NHLBI NIH HHS
- NICHD NIH HHS
- NINDS NIH HHS
Zitieren
APA
Jordan, L. C., King, A. A., Kanter, J., Lebensburger, J., Ford, A. L., Varughese, T. E., Garrett, L., Mullis, L., Saint Jean, L., Davis, S., Dumas, J., Kassim, A. A., Rodeghier, M., Hikima, M. S., Suwaid, M. A., Saleh, M. K., & DeBaun, M. R. (2024). Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033278
Vancouver
Jordan LC, King AA, Kanter J, Lebensburger J, Ford AL, Varughese TE, et al. Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.033278
BibTeX
@article{Jordan2024,
author = {Jordan, Lori C and King, Allison A and Kanter, Julie and Lebensburger, Jeff and Ford, Andria L and Varughese, Taniya E and Garrett, Lisa and Mullis, Lauren and Saint Jean, LeShana and Davis, Samantha and Dumas, Jeanine and Kassim, Adetola A and Rodeghier, Mark and Hikima, Mustapha S and Suwaid, Mohammad A and Saleh, Mohammed K and DeBaun, Michael R},
title = {Incidence and Risk Factors for New and Recurrent Infarcts in Adults With Sickle Cell Disease},
journal = {Journal of the American Heart Association},
year = {2024},
doi = {10.1161/jaha.123.033278}
}
EUVIMED